Table 4.

Respondents that reported use of gabapentinoids (from total survey respondents n = 10,062).

	Unweighted N (%)	Weighteda % (95% CI)
Lifetime use	1,003 (10.0%)	9.9 (9.2, 10.6)
Lifetime non-medical use	323 (3.2%)	2.9 (2.6, 3.3)
Last 12 month non-medical use	169 (1.7%)	1.5 (1.2, 1.7)
Last 90 day non-medical use	45 (0.4%)	0.4 (0.3, 0.6)
Last 30 day non-medical use	42 (0.4%)	0.4 (0.3, 0.6)
Last 7 day non-medical use	35 (0.3%)	0.4 (0.2, 0.5)

CI, Confidence Interval.

^aResponses are weighted to represent the distribution of adults (ages 15+) in Spain by region, gender, and age.